Top news of the week: 30.11.2022.
BioPharma Dynamics expands to provide more solutions for cell and gene therapy industry
BioPharma Dynamics have expanded their portfolio for the cell and gene therapy market to offer a range of chemically defined T-Cell media.
Pharma M&A rumour mill grinds out Mirati’s name again
KRAS inhibitor developer Mirati is rumoured to be a takeover candidate, analysts saying an offer could follow a key trial readout at ESMO
BIA rallying biopharma to oppose changes to UK tax credit system
The U.K. Bioindustry Association (BIA) is in an eleventh hour fight against changes to R&D tax breaks that it estimates will result in a £400 million to £800 million (US$480 million to ...
CinCor Plans Baxdrostat Phase III Despite Phase II Miss In Uncontrolled Hypertension
<p>With subgroup analysis that it claims shows efficacy in non-Hispanics and success in a previous Phase II in treatment-resistant hypertension, CinCor plans to outline Phase III plans to ...
Aptamer opens new facilities to meet growing demand for Optimer technology
Aptamer Group developer of Optimer binders that enable development in life sciences industry has opened new facilities in York Science Park.
How automation can help to address supply chain challenges in pharma
Empowering labs with automated equipment means pharmaceutical companies can ensure drug production runs smoothly
Executives On The Move: Aerie Pharmaceuticals, Valeo Pharma and More
<p><span style="color: black;">Recent executive changes in the industry include C-suite changes at ADC Therapeutics and ImmunoGen. Meanwhile, new directors were appointed at Aerie ...
Wireless smart bandage provides new insights on healing chronic wounds
Researchers at Stanford University report they have developed a wireless smart bandage that has shown promise in speeding tissue repair by monitoring the wound healing process and treating ...